We are live on
!
Find out more
Rockefeller Capital Management Portfolio holdings
AUM
$56.4B
1-Year Est. Return
24.96%
This Fund
S&P 500
This Quarter
Est. Return
-0.57%
1 Year Est. Return
+24.96%
3 Year Est. Return
+83.53%
5 Year Est. Return
+100.91%
10 Year Est. Return
–
AUM
$19B
AUM Growth
+$1.28B
(+7.2%)
Cap. Flow
+$1.55B
Cap. Flow
% of AUM
8.12%
Top 10 Holdings %
Top 10 Hldgs %
20.03%
Holding
3,992
New
448
Increased
1,822
Reduced
816
Closed
180
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Elanco Animal Health
ELAN
|
+$89.1M |
| 2 |
WEX
WEX
|
+$78.4M |
| 3 |
Blackrock
BLK
|
+$73.2M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$71.9M |
| 5 |
OneMain Financial
OMF
|
+$45.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$63.6M |
| 2 |
Neurocrine Biosciences
NBIX
|
+$56.6M |
| 3 |
Agnico Eagle Mines
AEM
|
+$55.1M |
| 4 |
DFS
Discover Financial Services
DFS
|
+$36M |
| 5 |
ORBC
ORBCOMM, Inc.
ORBC
|
+$27.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.39% |
| 2 | Financials | 14.65% |
| 3 | Healthcare | 12.11% |
| 4 | Consumer Discretionary | 7.54% |
| 5 | Industrials | 6.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Constellation Brands
STZ
$22.3B
| $37.4M | 0.2% |
177,703
+29,126
| +20% | +$6.36M |
|
|
VCRA
127
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
| $37.3M | 0.2% |
814,812
+1,236
| +0.2% | +$55.2K |
|
128
Abbott
ABT
$183B
| $37M | 0.19% |
313,023
-28,691
| -8% | -$3.52M |
|
129
Edwards Lifesciences
EW
$51.2B
| $36.3M | 0.19% |
320,562
-15,922
| -5% | -$1.82M |
|
130
Vanguard Extended Market ETF
VXF
$31.3B
| $36.2M | 0.19% |
198,298
+119,062
| +150% | +$22.2M |
|
131
Emerson Electric
EMR
$91B
| $35.7M | 0.19% |
379,080
+27,106
| +8% | +$2.7M |
|
132
Vanguard Morningstar Total Stock Market ETF
VTI
$681B
| $35.7M | 0.19% |
160,606
+33,659
| +27% | +$7.68M |
|
133
Vanguard FTSE Emerging Markets ETF
VWO
$123B
| $35.2M | 0.18% |
702,971
+49,343
| +8% | +$2.55M |
|
134
Simpson Manufacturing
SSD
$8.12B
| $34.7M | 0.18% |
324,431
+1,628
| +0.5% | +$180K |
|
135
Linde
LIN
$226B
| $34.4M | 0.18% |
117,264
+19,113
| +19% | +$5.81M |
|
136
Vanguard Morningstar Value ETF
VTV
$191B
| $34M | 0.18% |
251,316
+67,170
| +36% | +$9.35M |
|
137
Vanguard Morningstar Small-Cap Value ETF
VBR
$37.9B
| $34M | 0.18% |
200,657
+22,842
| +13% | +$3.91M |
|
138
RTX Corp
RTX
$300B
| $33.9M | 0.18% |
394,177
+55,272
| +16% | +$4.73M |
|
139
IBM
IBM
$222B
| $33.9M | 0.18% |
255,026
+20,554
| +9% | +$2.75M |
|
140
Amgen
AMGN
$220B
| $33.2M | 0.17% |
156,184
+16,291
| +12% | +$3.75M |
|
141
Vanguard Dividend Appreciation ETF
VIG
$114B
| $33.1M | 0.17% |
215,755
+29,128
| +16% | +$4.64M |
|
142
Chemed
CHE
$7.14B
| $33M | 0.17% |
71,037
+84
| +0.1% | +$39.6K |
|
143
Iron Mountain
IRM
$37.8B
| $32.3M | 0.17% |
744,175
+21,724
| +3% | +$978K |
|
144
Boeing
BA
$190B
| $31.8M | 0.17% |
144,366
+16,282
| +13% | +$3.63M |
|
145
Vanguard FTSE All-World ex-US ETF
VEU
$68B
| $31.3M | 0.16% |
514,208
+330,562
| +180% | +$20.8M |
|
146
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$46.7B
| $31.2M | 0.16% |
92,284
-13,450
| -13% | -$4.7M |
|
|
ABMD
147
DELISTED
Abiomed Inc
ABMD
| $31.1M | 0.16% |
95,616
-16
| -0% | -$5.42K |
|
148
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$33B
| $30.5M | 0.16% |
229,258
-63
| -0% | -$8.51K |
|
149
JPMorgan Ultra-Short Income ETF
JPST
$40.3B
| $30.3M | 0.16% |
597,458
+93,296
| +19% | +$4.73M |
|
150
Bank of America
BAC
$442B
| $30.3M | 0.16% |
713,633
+11,662
| +2% | +$470K |
|
Similar funds
NAMI
Rockefeller Capital Management's Q3 2021 Portfolio in Review
As of Q3 2021, Rockefeller Capital Management held 3,992 positions worth $19B, up 7.2% from $17.8B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Rockefeller Capital Management deployed $1.55B of net new capital in Q3 2021, opening 448 new positions and adding to 1,822 existing holdings. Its largest new stake was Darling Ingredients: 56,725 shares worth $4.08M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Regeneron Pharmaceuticals, an estimated $63.6M trimmed.
- Rockefeller Capital Management's largest Q3 2021 buy was Darling Ingredients: 56,725 shares worth $4.08M.
- Rockefeller Capital Management added most to Elanco Animal Health in Q3 2021, an estimated $89.1M increase.
- Rockefeller Capital Management's biggest Q3 2021 reduction was Regeneron Pharmaceuticals, cutting an estimated $63.6M.
- Rockefeller Capital Management fully exited ORBCOMM, Inc. in Q3 2021, selling an estimated $27.5M.
- Rockefeller Capital Management's ten largest holdings make up 20% of its $19B portfolio in Q3 2021.
- Rockefeller Capital Management opened 448 new positions and closed 180 in Q3 2021.
- Rockefeller Capital Management's portfolio value rose 7.2% quarter-over-quarter to $19B.
Based on Rockefeller Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.